OA-12 Interim Phase 2 Study Results of Durcabtagene Autoleucel (PHE885), a T-Charge™ Manufactured BCMA-Directed CAR-T Cell Therapy in Patients (pts) with r/r Multiple Myeloma (RRMM)

Article2022

PB1983: TRIAL-IN-PROGRESS: PHASE II STUDY OF PHE885, A B-CELL MATURATION ANTIGEN-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN ADULTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

N. Munshi, A. Spencer, M. S. Raab, Aisha Masood, M. Martinez-Prieto, Junjun Chu, Syouzou IIDA, S. Lonial, Meletios A Dimopoulos

Article2021

P-210: Oral ixazomib (Ixa), IV daratumumab (Dara), and dexamethasone (dex; IDd) in relapsed/refractory multiple myeloma (RRMM) patients (pts) with 1–3 prior therapies: phase 2 study interim analysis (IA)

Robert Z. Orlowski, Sosana Delimpasi, Jan Štraub, Argiris Symeonidis, Luděk Pour, Roman Hájek, Cyrille Touzeau, Viralkumar K. Bhanderi, Petr Pavlíček, Paweł Robak, Jesús G. Berdeja, Jeffrey Matous, Lionel Karlin, Sonja Zweegman, Sebastian Grosicki, Andrzej Pluta, Suman Kambhampati, Kaveri Suryanarayan, Philip Twumasi‐Ankrah, Ajeeta B. Dash, Richard Labotka, Meletios A Dimopoulos

Article2009

Efficacy and Safety of Retreatment with Bortezomib in Patients with Multiple Myeloma: Interim Results From RETRIEVE, a Prospective International Phase 2 Study.

Maria Teresa Petrucci, Igor W. Blau, Paolo Corradini, Meletios A Dimopoulos, Johannes Drach, Pilar Giraldo, Adriana Teixeira, Joan Bladé

Article2014

Carfilzomib (K) Vs Low-Dose Corticosteroids and Optional Cyclophosphamide (Cy) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma (Rrmm): Results from a Phase 3 Study (Focus)

Heinz Ludwig, Tamás Masszi, Maria Teresa Petrucci, Antonio Palumbo, Laura Rosiñol, Arnon Nagler, Kwee Yong, Jiří Minařík, Meletios A Dimopoulos, Vladimír Maisnar, Davide Rossi, H. Kasparu, Dina Ben‐Yehuda, Izhar Hardan, Matthew Jenner, Kanya Rajangam, Jesús F. San Miguel, Roman Hájek

Article2017

Phase 2 Study of the All-Oral Combination of Ixazomib Plus Cyclophosphamide and Low-Dose Dexamethasone (ICd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Shaji Kumar, Norbert Grząśko, Sossana Delimpasi, W Wiktor-Jędrzejczak, Sebastian Grosicki, Marie Christine Kyrtsonis, Andrew Spencer, Neeraj Gupta, Zhaoyang Teng, Catriona Byrne, Richard Labotka, Meletios A Dimopoulos

Discussion(0)

Related publications